Simulated alpha-blockade due to inhibition of release of nor-epinephrine by a beta-blocking agent Ko 592.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D002395:Catecholamines / Q000032:analysis; D003408:Cresols / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000097:blood; D005263:Femoral Artery / Q000032:analysis; D005725:Ganglia, Autonomic / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D008161:Lumbosacral Region; D009638:Norepinephrine / Q000037:antagonists & inhibitors* / Q000097:blood; D013565:Sympatholytics / Q000494:pharmacology*; D013997:Time Factors; D014666:Vasomotor System / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002395:Catecholamines; D003408:Cresols; D013565:Sympatholytics; D009638:Norepinephrine; D004837:Epinephrine